Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.48 USD | -5.15% | +1.85% | +51.24% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.24% | 2.55B | |
+75.35% | 12.54B | |
-22.51% | 7.71B | |
+7.88% | 6.72B | |
+12.49% | 5.38B | |
+37.02% | 4.89B | |
-16.99% | 4.71B | |
-25.08% | 3.75B | |
-27.15% | 2.77B | |
+0.99% | 2.05B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wells Fargo Upgrades NovoCure to Overweight From Equalweight, Adjusts Price Target to $89 From $74